Adjuvant chemotherapy (ACh) reduces the risk of recurrence and breast cancer (BC)-related death up to one third regardless of any clinical or pathologic factor, such as estrogen receptor (ER) expression [1]. The gene discussed is ESR1; the disease is breast cancer.